Pharmazeutische Rohstoffe Pulver Valsartan CAS: 137862-53-4

• Pulver: Ja
• Kundenspezifische: Kundenspezifische
• Bescheinigung: GMP, HSE, ISO 9001, USP, BP
• Passend für: Ältere, Kinder, Erwachsene
• Bundesland: Weißes Pulver
• Reinheit: > 99%
• Aussehen: Weißes Pulver
• Haltbarkeit: 2 Jahre
• Lagerung: An einem kühlen und trockenen Ort aufbewahren
• Lieferung: express 5-7 Tage Ankunft
• Testmethode: hplc
• Test: 99 %
• Versandbereich: Weltweit/alle Länder
• cas: 137862-53-4
• Service: Guter Service
• Liefermethode: fedex/dhl/Sonderlinie
• Produktname: Valsartan
• Transportpaket: Foil Bag
• Spezifikation: 99 %
• Warenzeichen: Xi′an Frazer Biotech Co., Ltd.
• Herkunft: China
• Produktionskapazität: 200kg Per Month

Produktbeschreibung

Pharmaceutical Raw Material Powder Valsartan CAS: 137862-53-4

Specification of Analysis

Product Name	Valsartan Powder
CAS	137862-53-4
Appearance	White or off white powder
Molecular formula	C29H30N6O6
Molecular Weight	435.51900
Assay	98%

What is Valsartan?

Valsartan is used clinical for receptor antagonist of angiotensin AT1, has good effect to the different degree of hypertension patients who used other antihypertensive drugs without efficacy , is a new generation of highly efficient antihypertensive drugs.
 

Function of Valsartan

 

Valsartan is used clinical for receptor antagonist of angiotensin AT1, has good effect to the different degree of hypertension patients who used other antihypertensive drugs without efficacy , is a new generation of highly efficient antihypertensive drugs.

 

Application of Valsartan

Valsartan (Angiotan) is an angiotensin II receptor antagonist (more commonly called an "ARB", or angiotensin receptor blocker), with particularly high affinity for the type I (AT1) angiotensin receptor. By blocking the action of angiotensin, valsartan dilates blood vessels and reduces blood pressure.[1] In the U.S., valsartan is indicated for treatment of high blood pressure, congestive heart failure (CHF), or post-myocardial infarction (MI).[2] In 2005, Angiotan was prescribed more than 12 million times in the United States and global sales were approximately $6.1 billion in 2010.[3]